The Real Differences: Mechanism, Storage & UK Costs Compared
Why Is Mounjaro Better Than Wegovy: Understanding the Key Mechanisms
The fundamental difference when comparing why is mounjaro better than wegovy lies in their pharmacological approach to appetite regulation. Mounjaro (tirzepatide) functions as a dual agonist, simultaneously targeting both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors, potentially offering broader metabolic effects. Wegovy (semaglutide) operates exclusively as a GLP-1 receptor agonist, mimicking the natural fullness hormone to reduce appetite and promote satiety after smaller meals.
This mechanistic difference means each medication may suit different patient profiles, though both require prescription-only medicine status and clinical assessment. The dual-action approach of Mounjaro theoretically provides additional pathways for weight management, whilst Wegovy's established GLP-1-only mechanism has extensive clinical validation through the STEP trial programme. Your prescriber can evaluate which approach aligns better with your individual medical history and treatment goals.
UK Pricing Transparency: Wegovy vs Mounjaro Cost Analysis
At EverydayMeds, we believe transparent pricing helps patients make informed decisions about why is mounjaro better than wegovy for their circumstances. Wegovy pricing starts at £79.99 for the 0.25mg starter dose (with code FIRST40 for new customers, DOSE25 for returning patients), progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our bundle options provide convenient multi-month supplies, such as the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99, covering your first three months of dose escalation.
Mounjaro pricing remains competitive across equivalent treatment phases, with both medications including full prescriber consultation, clinical assessment, and next-day cold-chain delivery. Unlike some providers, our stated prices include everything—no surprise consultation fees or delivery charges. Both treatments represent significant investments in your health, with the total monthly cost reaching maintenance levels around £210-£280 depending on your chosen medication and dose requirements.
Clinical Evidence: STEP vs SURMOUNT Trial Data
When evaluating why is mounjaro better than wegovy through clinical evidence, it's crucial to understand that direct comparisons remain limited due to different trial designs and patient populations. The STEP trials demonstrated Wegovy's efficacy, with STEP 1 showing approximately 15% average weight loss at 68 weeks when used alongside a reduced-calorie diet and increased physical activity (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial further showed a 20% reduction in major cardiovascular events.
Mounjaro's SURMOUNT trials have shown promising results in their own right, though comparing percentage outcomes directly between studies can be misleading due to varying methodologies and participant characteristics. Both medications require the same lifestyle modifications and demonstrate efficacy when used as prescribed under medical supervision.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy operates by mimicking GLP-1 (glucagon-like peptide-1), a naturally occurring hormone released by your intestines after eating. This hormone normally signals to your brain's appetite centres that you're becoming full, helping to regulate food intake naturally. By activating GLP-1 receptors more consistently than your body's natural hormone production, Wegovy may help reduce overall appetite and increase feelings of fullness after smaller portions. The medication also slows gastric emptying, meaning food stays in your stomach longer, contributing to sustained satiety between meals. This mechanism works best when combined with a reduced-calorie diet and increased physical activity, as the medication supports—rather than replaces—healthy lifestyle changes.
Streamlined UK Ordering Process
Getting started with either medication through EverydayMeds involves a straightforward three-step process designed to meet MHRA requirements whilst ensuring convenience. First, complete our 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Next, our UK-registered prescribers review your assessment—standard review takes 3 working days, or choose our express 24-hour service for faster processing. Once approved, your prescription-only medicine ships via next-day cold-chain delivery, maintaining the required 2-8°C temperature throughout transit. Our GPhC #9012878 registered pharmacy ensures full regulatory compliance, whilst our clinical team remains available for ongoing support throughout your treatment journey.
Storage and Practical Considerations
A practical advantage when considering why is mounjaro better than wegovy involves storage flexibility, particularly for frequent travelers. Wegovy can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require refrigerated storage at 2-8°C before first use and utilise pre-filled injection pens for weekly self-administration. The dose escalation schedule differs slightly between medications, with Wegovy following a standardised 4-week progression through each dose level (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg) to minimise gastrointestinal side effects. Neither medication should be frozen, and both feature user-friendly pen designs suitable for self-injection after proper training.
UK Market Access and Prescriber Choice
The question of why is mounjaro better than wegovy often depends on individual patient factors that only qualified prescribers can properly assess. Wegovy benefits from established NICE guidance (TA875) recommending its use within specialist weight management services, providing clear pathways for NHS and private prescription access. Both medications require BMI thresholds of ≥30, or ≥27 with weight-related comorbidities, alongside demonstrated commitment to lifestyle modifications.
Prescriber experience varies between the two options, with Wegovy having longer UK market presence and more extensive prescriber familiarity. However, growing clinical experience with Mounjaro's dual-agonist approach is expanding prescriber confidence in this newer option. Your consultation will explore factors like previous GLP-1 experience, specific health conditions, lifestyle requirements, and cost considerations to determine the most appropriate choice.
Making Your Decision: Value, Efficacy and Ongoing Support
Rather than definitively answering why is mounjaro better than wegovy, the optimal choice depends on balancing clinical suitability, practical requirements, and cost considerations specific to your situation. Both medications are available through EverydayMeds with identical support standards—comprehensive clinical assessment, ongoing prescriber access, reliable cold-chain delivery, and transparent pricing including discount codes FIRST40 (new customers) or DOSE25 (returning patients). Our clinical team can discuss how each medication's distinct mechanism might align with your medical history and treatment goals.
Consider booking your initial consultation to explore both options with a qualified prescriber who can provide personalised recommendations. With competitive pricing, comprehensive support, and access to both leading weight management medications, EverydayMeds ensures you have the information and clinical guidance needed to make the right choice for your health journey. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment today.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
